ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Is There a Clinically Meaningful Difference between "Preformed" and "De Novo" Alloantibodies in Negative Crossmatch Renal Transplantation?

    M. Everly, L. Rebellato, K. Briley, C. Morgan, P. Bolin, W. Kendrick, S. Kendrick, C. Haisch, R. Harland, P. Terasaki

    Terasaki Foundation, Los Angeles, CA; East Carolina University, Greenville, NC; Eastern Nephrology and Associates, Greenville, NC

    Researchers have long categorized DSA into 2 types: preformed and de novo. However, there have been no studies that directly compare the 2 entities. Herein,…
  • 2013 American Transplant Congress

    Tighter Pretransplant Glycemic Control Is Associated with Reduced Cardiovascular Events after Kidney Transplant in Diabetic Patients at 5 and 10 Year Follow-Up

    J. Tong, A. Shields, D. Hanseman, R. Alloway, S. Woodle

    University of Cincinnati, Cincinnati

    Data on the impact of pretransplant glycemic control on posttransplant cardiovascular (CV) outcome and survival is limited and inconsistent. We hypothesized that tighter glycemic control…
  • 2013 American Transplant Congress

    First Year Mild Renal Insufficiency Associated with Increased Mortality after Heart Transplant

    J. Patel, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, J. Kobashigawa

    Cedars-Sinai Heart Institute, Los Angeles, CA

    BACKGROUND: Renal failure has been a consistent risk factor for mortality after heart transplantation. From the ISHLT Registry approximately one third of patients have an…
  • 2013 American Transplant Congress

    Outcomes Following Positive Crossmatch Renal Transplantation Despite Failure To Convert to Negative Flow Crossmatch after Desensitization

    S. Patel, J. Joseph, S. Akkina, P. West-Thielke, J. Thielke, J. Oberholzer, E. Benedetti

    Pharmacy Practice, University of Illinois Hospital and Health Sciences System, Chicago, IL; Medicine, University of Illinois Hospital and Health Sciences System, Chicago, IL; Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL

    Purpose: Determine outcomes of positive crossmatch (PXM) renal transplant recipients that failed to convert to negative flow cytometry crossmatch (FCXM) despite desensitization.Methods: All patients that…
  • 2013 American Transplant Congress

    North American Results from the Multicenter Randomized Trial of Everolimus vs Mycophenolate Mofetil in Heart Transplantation

    J. Kobashigawa, D. Pauly, H. Ross, A. Kfoury, A. Van Bakel, D. Patel, A. Wiland, P. Lopez, A. Balfour, R. Starling, H. Eisen

    Cedars-Sinai Heart Institute, CA; University of Florida College of Medicine, FL; Toronto General Hospital, Toronto, Canada; Intermountain Medical Center, UT; Medical University of South Carolina, SC; Novartis Pharmaceuticals Corp, NJ; Novartis Pharma AG, Basel, Switzerland; Cleveland Clinic, OH; Drexel University College of Medicine, PA

    Purpose: 24-month (M) results of a randomized, open-label, multinational study (A2310) comparing efficacy and safety of everolimus (EVR) and mycophenolate mofetil (MMF) in de novo…
  • 2013 American Transplant Congress

    Comparison of Hepatitis C Recurrence in Orthotopic Liver Transplant Recipients Receiving Antibody Induction Versus No Antibody Induction

    S. Patel, P. West-Thielke, H. Jeon, E. Benedetti, J. Thielke

    Pharmacy Practice, University of Illinois Hospital and Health Sciences System, Chicago, IL; Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL

    Purpose: Compare the incidence of hepatitis C virus (HCV) recurrence in orthotopic liver transplant (OLT) recipients receiving induction to subjects that were transplanted without induction…
  • 2013 American Transplant Congress

    Determinants of Late Acute Rejection in Pediatric & Adolescent Kidney Transplant Recipients

    L. Eid, S. Tuchman, A. Moudgil

    Pediatric Nephrology, Children's National Medical Center, Washington, DC

    Background: Long-term graft function has not kept pace with short-term graft survival in children. Late Acute Rejection (LAR) episodes are in part responsible for the…
  • 2013 American Transplant Congress

    Nonmyeloablative Conditioning Regimen with B Cell Depletion and Long-Term Outcome of HLA Mismatched Combined Kidney and Bone Marrow Transplantation without Maintenance Immunosuppression

    T. Kawai, D. Sachs, B. Sprangers, T. Spitzer, N. Tolkoff-Rubin, S. Saidman, E. Zorn, W. Williams, R. Smith, R. Colvin, M. Sykes, A. Cosimi

    Massachusetts General Hsopital, Boston, MA; Translational Immunology, Columbia University, New York, NY

    Background: We report the long-term results (up to 10 years) of one-haplotype HLA mismatched kidney transplantation without maintenance immunosuppression (IS) following combined kidney and bone…
  • 2013 American Transplant Congress

    Factors Implicated in the Expression of Selenium Binding Protein 1 in Chronic Allograft Vasculopathy

    J. Torrealba, D. Roenneburg, A. Djamali

    Pathology, University of Texas Southwestern Medical Center, Dallas, TX; Surgery, University of Wisconsin, Madison, WI; Medicine, University of Wisconsin, Madison, WI

    Background: Selenium binding protein-1 (SBP-1) has been implicated in intracellular protein trafficking and secretion. In a rhesus monkey kidney transplant model we previously demonstrated that…
  • 2013 American Transplant Congress

    Where Are the Real Barriers in Post Mortem Organ Donation?

    M. Kosieradzki, A. Jakubowska-Winecka, K. Kusza, W. Rowinski

    Dept. of General & Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland; Dept. of Health Psychology, Children's Memorial Health Institute, Warsaw, Poland; Dept. of Anesthesiology & Intensive Care, Collegium Medicum of Nicolaus Copernicus University, Bydgoszcz, Poland; Dept. of Surgery, University of Warmia & Mazury, Olsztyn, Poland; Polish Union for Transplantation Medicine, Warsaw, Poland

    Low organ donation rate from deceased donors (DD) is believed to result from the societal misperception and non-acceptance of brain death.However, it has been shown…
  • « Previous Page
  • 1
  • …
  • 1658
  • 1659
  • 1660
  • 1661
  • 1662
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences